ACHV
Achieve Life Sciences Inc
7.20$
+3.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.6% | -3.2% | +1.6% | -3.2% | -6.7% | -1.8% | +18.2% | +0.0% | +53.8% | +0.0% | -43.0% | +0.0% | +0.0% | +0.0% | – | – | -11.3% | -1.8% | +5.6% | +0.0% | – | – | |
| – | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -154.4% | – | – | – | – | – | – | |
| – | -55.0% | -46.4% | -14.8% | +6.2% | +161.0% | -44.2% | -13.0% | +47.5% | +35.0% | +94.9% | -49.9% | -10.2% | -3.3% | -12.6% | -28.4% | +71.4% | +24.1% | +140.4% | +63.5% | -50.2% | -1.9% | -2.6% | +64.2% | +36.9% | -12.7% | -35.8% | -17.1% | -21.9% | -41.0% | +32.4% | +82.7% | +48.8% | -4.1% | -2.7% | -5.5% | -20.7% | -27.2% | -15.0% | +15.7% | – | |
| – | +23.1% | +10.3% | -8.3% | -33.2% | +5.1% | +11.3% | -3.4% | +0.1% | -7.1% | +15.8% | -13.5% | +16.1% | -23.6% | +25.6% | -0.1% | +2.6% | +27.4% | -1.3% | -11.4% | +1.3% | +24.1% | +8.8% | +1.0% | -3.3% | -18.8% | +35.4% | +2.8% | -4.4% | -24.0% | +40.1% | +4.2% | +46.4% | +0.8% | +18.5% | +1.0% | +60.0% | +15.8% | -34.5% | +105.0% | – | |
| – | -29.2% | -13.8% | -10.0% | -23.3% | +59.2% | -20.3% | -7.2% | +17.8% | +12.6% | +60.2% | -38.4% | +1.5% | -13.7% | +4.6% | -13.1% | +28.6% | +25.8% | +69.1% | +41.6% | -40.8% | +6.3% | +1.6% | +39.4% | +25.5% | -14.1% | -21.0% | -10.1% | -16.1% | -32.2% | +36.4% | +40.9% | +47.9% | -2.2% | +5.8% | -2.6% | +16.5% | +0.6% | -29.4% | +76.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -20.0% | -25.0% | +0.0% | -66.7% | +0.0% | +0.0% | +100.0% | +205.0% | +36.1% | -25.3% | -33.9% | -2.4% | -32.5% | +55.6% | -92.9% | -33.3% | +1,000.0% | -63.6% | -62.5% | +0.0% | +0.0% | +11,800.0% | +13.2% | +19.1% | +13.7% | +4.8% | +24.3% | +9.7% | +0.8% | +3.3% | -1.1% | -54.5% | -46.2% | -6.1% | +3.2% | +0.5% | +30.7% | +9.2% | +1.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +863.9% | +16.4% | +19.1% | -150.3% | – | – | – | -97.1% | +4.1% | -733.9% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.